Las Vegas, USAPolymyositis Pipeline to Progress with New and Emerging Drugs for Treatment, Analyzes , Dec. 08, 2021 (GLOBE NEWSWIRE) -- DelveInsight’s ‘Polymyositis Pipeline Insight 2021’ report ...

Please provide your email address to receive an email when new articles are posted on . Among systemic rheumatic diseases, the risk for opportunistic infection is highest among patients with ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Handheld dynamometry, a new, inexpensive and quantitative compact device, proved reliable and ...

Q: I started to develop weakness that made it hard for me to get out of a chair. My doctor thinks it may be polymyositis and referred me to a specialist. What is this disease? A: Polymyositis (PM) is ...

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Polymyositis pipeline constitutes 7+ key companies continuously working towards developing 7+ Polymyositis treatment ...

New research from Tokyo, Japan could help clarify the role of proinflammatory mediators in the pathogenesis of chronic inflammatory myopathies, such as polymyositis and dermatomyositis. Elevated ...

CORONA, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, ...

Keep abreast with the latest news related to Polymyositis there are 13 news items on Polymyositis that covers updates, breakthroughs and in-depth reports. We provide you with a free downloadable ...

Systemic Lupus Erythematosus (SLE): SLE is an autoimmune disorder in which the immune system of the body attacks its own cells instead for fighting against foreign bacteria and other harmful ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on the polymyositis market. The report includes a detailed analysis of the pipeline molecules under investigation ...

Inflammatory myopathies are the largest group of potentially treatable myopathies in children and adults. They constitute a heterogeneous group of disorders that are best classified, on the basis of ...